NEW COAS IN ONCOLOGY GUIDE
QM COAs can help capture slowed decline in physical functioning and well-being. Learn how to illuminate the impact of cancer treatments and therapies using COA measures in a free oncology-focused guide.
Read the GuideThe copyright owners of SF-36v2® and SF-12v2® Health Surveys.
The copyright owners of SF-36v2® and SF-12v2® Health Surveys.
Our research consultants have decades of experience in PRO measurement across diverse therapeutic conditions. We work closely with pharmaceutical, medical device and healthcare organizations on data measurement that aligns with regulatory recommendations in the U.S. and other geographies. Our scientifically led approach includes the analysis of any PRO measure, the burden of illness, and treatment effectiveness.
Scientific ConsultingQualityMetric’s eCOA platform is a robust data collection, scoring and reporting portal. It can be custom tailored with the features and functionality needed to securely and accurately capture data from patients, clinicians or caregivers. Our scientists combine health outcomes expertise with our technology platform to identify the right measurement concepts for collecting the most insightful and patient-centric evidence.
COA Solutions & Licensing ServicesQualityMetric offers unique solutions for translation and cross-cultural adaptation. Guided by industry standards, we translate and validate all types of materials used in healthcare and the life sciences. We collaborate with hundreds of experienced local and international linguistic partners, overseeing every stage of the development process. Our goal is absolute conceptual equivalence, cultural appropriateness and content validity.
Translation & Linguistic ValidationQualityMetric’s Short Form family of generic health surveys – in particular the SF-36v2® and SF-12v2® Health Surveys – includes the most widely used and cited PROs in the world. Designed for use across the product lifecycle, they are an efficient, scientifically valid way of evaluating safety and efficacy, real world evidence through product performance, and post authorization safety surveillance; and they support post-launch direct-to-consumer (DTC) marketing and disease management.
QualityMetric collaborates with the world’s largest life science and healthcare organizations to measure and better understand health outcomes. We are also committed to supporting global academic institutions by making our clinical outcome assessment (COA) solutions royalty-free for unfunded students and university researchers.
From health surveys to expert analysis and methodologies, QualityMetric delivers all-inclusive outcome measurement solutions for capturing, benchmarking, and interpreting actionable patient-reported health information. For licensing requests, scientific consulting services, or linguistic translation and validation, please complete the following contact form.
Select the organization that best describes your company:
Please answer the following questions and we will be in touch regarding your license
QualityMetric is reviewing your application and will get back to you shortly with approval to move forward with a license to administer, collect, score, and interpret the data for your project/study.
Next steps:
If you have started administering the survey, please email a copy of the survey being administered to [email protected]. We will QA the form for any changes that may affect the scoring and interpretation of the data collected. (Fees may apply).
If you are applying for a student license, please email a copy of your student ID to [email protected].
Assessing health-related quality of life (HRQoL) offers a significant amount of information on a person’s physical, mental, emotional and social well-being, and it can serve as a multifaceted metric in examining endocrine and metabolic disorders. As more healthcare professionals and researchers adopt a patient-centered approach to clinical research and care, they increasingly turn to patient-reported outcomes (PROs) as a method of capturing HRQoL.
Advancing COPD Clinical Trials: The Role of the COPD Population Screener (COPD-PS) Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease that causes breathing difficulties and severely impacts the quality of life for millions of people worldwide. As one of the leading causes of death and disability globally,1 COPD has become a focal point […]
Read MoreThe QualityMetric team is attending the ISOQOL 31st Annual Conference. We’ll be contributing to ISOQOL 2024 through two symposiums, a research presentation, and two featured papers. Our scientists look forward to connecting with the global QOL community of researchers, clinicians, health care professionals, industry professionals, consultants and patient research partners. Join us in Cologne, Germany […]
Read MoreAdvancing Women’s Health Research: The Role of Patient-Reported Outcome Measures The healthcare industry has long faced a shortage of impactful research and treatments that specifically target current issues in women’s health, from breast and cervical cancers, to maternal health and menopause-related conditions, to autoimmune diseases and mental health challenges. Making progress on women’s health research […]
Read MoreThe Benefits of Using PROs in Vaccine Research & Development As healthcare systems face multiple epidemics of flu, pneumonia, respiratory syncytial virus (RSV), and COVID infections, the industry is racing to research and develop vaccines that can help safeguard public health. The RSV vaccine market is expected to grow by an estimated $4 billion USD […]
Read MoreHITRUST certification validates QualityMetric is operating leading security practices to protect sensitive healthcare Information. Rhode Island, March 18, 2024 — QualityMetric (QM)—an IQVIA business, a leading global clinical outcomes assessments (COA) solutions provider and scientific consultancy specializing in patient-reported outcomes (PRO)—has announced its Smart Measurement System has earned the recent achievement of certified status by HITRUST for information […]
Read MoreUsing PRO Measures in Amyloidosis Research Amyloidosis refers to a group of rare diseases caused by the buildup of misfolded proteins in various tissues and organs in the body, often leading to organ damage and impaired quality of life. 1Given the rareness of systemic amyloidosis, there can be limited opportunities to gather data on the […]
Read More